Search - tctmd.com

Displaying 1 - 18 of 18

Sort: Relevancy | Date

Presentation TVT 2016

The Case for and Against Cerebral Embolic Protection During TAVR

Presenter: Susheel Kodali

June 16, 2016

Presentation TVT 2015

Cerebral Protection Devices Are Still Meaningful and Necessary

Presenter: Eberhard Grube

June 05, 2015

Presentation TVT 2014

A Critical Analysis of Present Data on Cerebral Protection after TAVR

Presenter: Axel Linke

June 07, 2014

Presentation TVT 2014

Why Cerebral Protection after TAVR Will Become the Standard of Care

Presenter: Eberhard Grube

June 07, 2014

Presentation TVT 2014

Why Cerebral Protection after TAVR Will be Used Sparingly (if at all) in the Future

Presenter: Ganesh Manoharan

June 07, 2014

Presentation TVT 2014

Has Stroke Frequency Declined After TAVR?

Presenter: Nicolas M. van Mieghem

June 07, 2014

Presentation TVT 2014

Perspectives from the US CoreValve Trials

Presenter: Jeffrey J. Popma

June 07, 2014

Presentation TVT 2014

Perspectives from the PARTNER Trials

Presenter: Susheel Kodali

June 07, 2014

Presentation TVT 2014

Incidence, Timing, Predictors (New Onset AF, Postdilatation, etc.), and Clinical Impact

Presenter: Samir R. Kapadia

June 07, 2014

Presentation TVT 2014

Technology Overview and Clinical Trial Status (DEFLECT I and Other Trials)

Presenter: Alexandra J. Lansky

June 06, 2014

Presentation TVT 2014

Introduction to the US FDA-Approved Sentinel TAVR Safety and Efficacy Study

Presenter: Susheel Kodali

June 06, 2014

Presentation TVT 2014

Histo-Pathology Debris Analysis and Status of the MISTRAL C Randomized Trial

Presenter: Nicolas M. van Mieghem

June 06, 2014

Presentation TVT 2014

Technology Overview and Status of the CLEAN-TAVI Randomized Trial

Presenter: Axel Linke

June 06, 2014

Presentation TVT 2014

Technology Overview and Clinical Trial Status (Pilot Phase of PROTAVI C and Beyond)

Presenter: Alec S. Vahanian

June 06, 2014

Presentation TVT 2013

Cerebral Embolic Protection Devices

Presenter: Eberhard Grube

June 14, 2013

Presentation TVT 2012

Overview of Cerebral Protection Devices

Presenter: Eberhard Grube

June 05, 2012

Presentation TVT 2012

Will Cerebral Embolic Protection Devices Reduce Strokes After TAVR?

Presenter: Josep Rodes-Cabau

June 04, 2012

Presentation TVT 2012

Complication of a Cerebral Protection Device

Presenter: 204222|Ronald Binder

June 02, 2012

Advertisement

The Case for and Against Cerebral Embolic Protection During TAVR

Cerebral Protection Devices Are Still Meaningful and Necessary

A Critical Analysis of Present Data on Cerebral Protection after TAVR

Why Cerebral Protection after TAVR Will Become the Standard of Care

Why Cerebral Protection after TAVR Will be Used Sparingly (if at all) in the Future

Has Stroke Frequency Declined After TAVR?

Perspectives from the US CoreValve Trials

Perspectives from the PARTNER Trials

Incidence, Timing, Predictors (New Onset AF, Postdilatation, etc.), and Clinical Impact

Technology Overview and Clinical Trial Status (DEFLECT I and Other Trials)

Introduction to the US FDA-Approved Sentinel TAVR Safety and Efficacy Study

Histo-Pathology Debris Analysis and Status of the MISTRAL C Randomized Trial

Technology Overview and Status of the CLEAN-TAVI Randomized Trial

Technology Overview and Clinical Trial Status (Pilot Phase of PROTAVI C and Beyond)

Cerebral Embolic Protection Devices

Overview of Cerebral Protection Devices

Will Cerebral Embolic Protection Devices Reduce Strokes After TAVR?

Complication of a Cerebral Protection Device

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content